Respiratory Effectiveness Group (REG) Summit 2016
Lyon, France, 15 – 16 April

POSTERS

Underuse of beta-blockers in patients with heart failure and COPD

Pragmatic randomised trial comparing continuing Seretide® MDI with changing to Flutiform® in asthma

Comparative effectiveness of prescribing similar versus dissimilar inhalers for COPD therapy (phase 1)

Determinants of increased FeNO in individuals with suspected asthma

Pragmatic randomised trial stepping down Flutiform® in patients maintained on high dose ICS

Comparative effectiveness of prescribing similar versus dissimilar inhalers for COPD therapy (phase 2)

Drug-related costs of rhinitis in Australia: a NostraData cross-sectional study of pharmacy purchases

Effectiveness and cost impact evaluation of fluticasone propionate/formoterol compared to fluticasone propionate/salmeterol

Opportunities for real-life respiratory research in Korea: the HIRA database and beyond

ABSTRACTS

Allergy Working Group Update: the burden and management of rhinitis and rhinosinusitis in UK primary care
Fokkens W, Nibber A, Chisholm A, Hellings P, Skinner D, et al.
J Thorac Dis 2016; 8(5): AB042. [Full Text]

Effectiveness and cost impact evaluation of fluticasone propionate/formoterol compared to fluticasone propionate/salmeterol
Ming SW, Small I, Wolfe S, Hamil J, Gruffydd-Jones K, et al.
J Thorac Dis 2016; 8(5): AB041. [Full Text]

Determinants of increase FeNO in individuals with suspected asthma
Batsiou M, Kreuzaler S, Gardener E, Ryan D, Gruffydd-Jones K, et al.
J Thorac Dis 2016; 8(5): AB040. [Full Text]

Pragmatic trial stepping down Flutiform® in patients maintained on high dose ICS. Pragmatic trial stepping down Flutiform® in patients maintained on high dose ICS
Kemppinen A, Gardener E, Thomas V, Raju P, Callan C, et al.
J Thorac Dis 2016; 8(5): AB039. [Full Text]

Pragmatic trial comparing continuing Seretide® MDI with changing to Flutiform® in asthma
Kemppinen A, Gardener E, Thomas V, Raju P, Callan C, et al.
J Thorac Dis 2016; 8(5): AB038. [Full Text]

Drug-related costs of rhinitis in Australia: a NostraData cross-sectional study of pharmacy purchases
Carney AS, Price DB, Smith P, Harvey R, Bosnic-Anticevich S, et al.
J Thorac Dis 2016; 8(5): AB037. [Full Text]

Real-life experience of COPD patients on ease and accuracy of inhaler use: the REAL survey
Keininger DL, Price D, Viswanad B, Gasser M, Walda S
J Thorac Dis 2016; 8(5): AB036. [Full Text]

Comparative effectiveness of prescribing similarversusdissimilar inhalers for COPD therapy
Bosnic-Anticevich S, Chrystyn H, Costello R, Dolovich M, Fletcher M, et al.
J Thorac Dis 2016; 8(5): AB034. [Full Text]

Opportunities for real-life respiratory research in Korea: the HIRA database and beyond
van Boven JF, Rhee CK, Park HY, Yoo KH, Kim DK, et al.
J Thorac Dis 2016; 8(5): AB032. [Full Text]

Long-acting beta-agonist in combination or separate inhaler as step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids
Turner S, Richardson K, Murray C, Thomas M, Hillyer EV, et al.; on behalf of the Respiratory Effectiveness Group
J Thorac Dis 2016; 8(5): AB027. [Full Text]. Published as [PubMed] [Full Text]

Inappropriate asthma therapy: a tale of two countries
Nibber A, Belhassen M, Van Ganse E, Ryan D, Langlois C, et al.
J Thorac Dis 2016; 8(5): AB013. [Full Text]

Current burden of uncontrolled asthma in the general population: the OPCRD asthma State of the Union study
Nibber A, Thomas M, Thomas V, van Aalderen W, Bleecker E, et al.
J Thorac Dis 2016; 8(5): AB012. [Full Text]